Northwest Biotherapeutics Inc (QB) (NWBO) Fundamentals

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA.
Share Info
Market Cap$ 968,625,652
Shares Authorized1,200,000,000
Shares Outstanding1,052,853,970
Shares Outstanding Date11/23/2022
Shareholder Count41,900
Shareholder Count Date03/01/2022
Float Date05/02/2022
Short Interest27,335,566
Short Interest Date10/31/2022
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
AuditorCherry, Bekaert & Holland, L.L.P.
Auditor Address401 East Jackson St
Suite 3400
Tampa, Florida 33602
Auditor Website
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselGibson Dunn
Legal Counsel Address1050 Connecticut Avenue, N.W.
Washington, DC, Washington DC 20036
Legal Counsel Website-
Fiscal Year End12/31
ADR Ratio-
Transfer AgentComputershare U.S.
Transfer Agent Address150 Royall Street
Canton, MA 02021
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:NWBO
OTC Market TierOTCQB
Security TypeCommon Stock
CIK Number0001072379
Address4800 Montgomery Lane
Suite 800
Bethesda, Maryland 20814
Phone(240) 497-9024
Fax #-
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesDir. - Dr. Alton Boynton
CTO - Marnix Bosch
Dir. - Cofer Black
Consultant - Tamara Kondic
CIO - Jean Davis
Dir. - Navid Malik
General Counsel - Leslie Goldman
Consultant - Bruce Poignant
Dir. - Jerry Jasinowski
CEO - Linda Powers
Number of Employees20
Incorporation StateDelaware
Incorporation CountryUSA
Incorporation Year1998
Your Recent History
Northwest ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221203 08:38:08